Japan
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The court plans to introduce a system for expert-led SEP mediation, intended to help parties come to an agreement within three sessions
The model covers court-guided settlements, submissions-led determination of infringement and validity issues, and provides leeway for the court to determine a FRAND rate during negotiations
Sponsored
Sponsored
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office says the decision by the Grand Panel of the Intellectual Property High Court provides a practical benchmark for calculating damages in cosmetic and medical patent infringement cases -
Sponsored by IP WorkEleni Lappa of IP Work explains how Japanese companies can protect intellectual property and resolve disputes in Europe, with insights on alternative dispute resolution, patents, trademarks, and the challenges of AI and cross-border regulation
-
Sponsored by Shiga International Patent OfficeYuki Tsukada of Shiga International Patent Office says the rulings will ease enforcement of patent rights on network-related inventions and suggests legislative reform may be on the horizon
-
Sponsored by Bird & BirdSeiko Hidaka of Bird & Bird and Kento Sumi, currently seconded to Bird & Bird, analyse a landmark decision in a standard-essential patent case and its implications for licensing practices and future litigation in Japan
-
Sponsored by Satyapon & PartnersKritsana Mingtongkhum and Shantanu Ajit Tambe of Satyapon & Partners provide a guide to claiming trademark infringement damages in Thailand, and suggest an approach that could offer quicker resolution and yield a higher amount
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains what types of bio inventions are deemed eligible for patent protection in Japan and draws comparisons with US practice
